There are two hypotheses explaining a fulminant outcome after hepatitis B virus (HBV) infection, both of which may be applicable at the same time: (i) basal core promoter (BCP) mutations increase viral replication, allowing rapid spread of the virus through the liver, and (ii) pre-core (pre-C) mutations abrogating hepatitis B e antigen (HBeAg) synthesis remove its tolerogenic effect, leading to a vigorous immune response. This study investigated the effect of these mutations on virus replication efficiency and HBeAg production. Substitutions A1762T/G1764A and T1753C, C1766T and T1768A in the BCP region, and G1896A and G1899A in the pre-C region, were examined either alone or in combination, using a common genetic background. Huh7 cells were transfected with these constructs and real-time PCR was used to quantify released virion-associated and intracellular HBV DNA, pregenomic RNA and pre-C mRNA. In addition, culture supernatants were tested for hepatitis B surface antigen (HBsAg) and HBeAg. The double BCP mutation (A1762T/G1764A) and the pre-C mutations (G1896A, G1899A), either alone or in combination, had no appreciable effect on the replication capacity of the virus. In contrast, clones with mutations at positions 1766/1768, 1762/1764/1766 and 1753/1762/1764 exhibited increased-replication phenotypes. HBeAg was undetectable in all cultures transfected with constructs bearing the G1896A stop-codon mutation, as expected. In contrast, constructs with additional mutations in the BCP region had appreciably lower levels of HBeAg expression than the wild type. Thus, core promoter mutations other than those at 1762/1764 appear to upregulate viral DNA replication and, at the same time, greatly reduce HBeAg production.
BaumertT. F.,
RogersS. A.,
HasegawaK.,
LiangT. J.1996; Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 98:2268–2276[CrossRef]
BaumertT. F.,
MarroneA.,
VergallaJ.,
LiangT. J.1998; Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression. J Virol 72:6785–6795
BuckwoldV. E.,
XuZ.,
ChenM.,
YenT. S.,
OuJ. H.1996; Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 70:5845–5851
BuckwoldV. E.,
XuZ.,
YenT. S.,
OuJ. H.1997; Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication. J Gen Virol 78:2055–2065
CarmanW. F.,
JacynaM. R.,
HadziyannisS.,
KarayiannisP.,
McGarveyM. J.,
MakrisA.,
ThomasH. C.1989; Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2:588–591
CarmanW. F.,
FaganE. A.,
HadziyannisS.,
KarayiannisP.,
TassopoulosN. C.,
WilliamsR.,
ThomasH. C.1991; Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology 14:219–222[CrossRef]
ChuC. M.,
KarayiannisP.,
FowlerM. J.,
MonjardinoJ.,
LiawY. F.,
ThomasH. C.1985; Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 5:431–434[CrossRef]
FriedtM.,
GernerP.,
LauschE.,
TrubelH.,
ZabelB.,
WirthS.1999; Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 29:1252–1258[CrossRef]
FuL.,
ChengY. C.1998; Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in l(−)SddC (3TC) resistance. Biochem Pharmacol 55:1567–1572[CrossRef]
GuntherS.,
PiwonN.,
WillH.1998; Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) to T, A(1762) to T and G(1764) to A mutations in the core promoter. J Gen Virol 79:375–380
HasegawaK.,
HuangJ.,
RogersS. A.,
BlumH. E.,
LiangT. J.1994; Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol 68:1651–1659
KanekoM.,
UchidaT.,
MoriyamaM.,
ArakawaY.,
ShikataT.,
GotohK.,
MimaS.1995; Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B. J Med Virol 47:204–208[CrossRef]
KosakaY.,
TakaseK.,
KojimaM.,
ShimizuM.,
InoueK.,
YoshibaM.,
TanakaS.,
AkahaneY.,
OkamotoH.,
TsudaF.1991; Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 100:1087–1094
LarasA.,
KoskinasJ.,
HadziyannisS. J.2002; In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter. Virology 295:86–96[CrossRef]
LiJ.,
BuckwoldV. E.,
HonM. W.,
OuJ. H.1999; Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J Virol 73:1239–1244
LiangT. J.,
HasegawaK.,
RimonN.,
WandsJ. R.,
Ben-PorathE.1991; A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 324:1705–1709[CrossRef]
McMillanJ. S.,
BowdenD. S.,
AngusP. W.,
McCaughanG. W.,
LocarniniS. A.1996; Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation. Hepatology 24:1371–1378[CrossRef]
MilichD. R.,
JonesJ. E.,
HughesJ. L.,
PriceJ.,
RaneyA. K.,
McLachlanA.1990; Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero ?. Proc Natl Acad Sci U S A 87:6599–6603[CrossRef]
MoriyamaK.1997; Reduced antigen production by hepatitis B virus harbouring nucleotide deletions in the overlapping X gene and precore-core promoter. J Gen Virol 78:1479–1486
MoriyamaK.,
OkamotoH.,
TsudaF.,
MayumiM.1996; Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. Virology 226:269–280[CrossRef]
OkamotoH.,
YotsumotoS.,
AkahaneY.,
YamanakaT.,
MiyazakiY.,
SugaiY.,
TsudaF.,
TanakaT.,
MiyakawaY.,
MayumiM.1990; Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 64:1298–1303
OkamotoH.,
TsudaF.,
AkahaneY.,
SugaiY.,
YoshibaM.,
MoriyamaK.,
TanakaT.,
MiyakawaY.,
MayumiM.1994; Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 68:8102–8110
OmataM.,
EhataT.,
YokosukaO.,
HosodaK.,
OhtoM.1991; Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 324:1699–1704[CrossRef]
PollackJ. R.,
GanemD.1994; Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis. J Virol 68:5579–5587
RaneyA. K.,
JohnsonJ. L.,
PalmerC. N.,
McLachlanA.1997; Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J Virol 71:1058–1071
SatoS.,
SuzukiK.,
AkahaneY.,
AkamatsuK.,
AkiyamaK.,
YunomuraK.,
TsudaF.,
TanakaT.,
OkamotoH.other authors1995; Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 122:241–248[CrossRef]
ScaglioniP. P.,
MelegariM.,
WandsJ. R.1997; Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology 233:374–381[CrossRef]
SterneckM.,
GuntherS.,
SantantonioT.,
FischerL.,
BroelschC. E.,
GretenH.,
WillH.1996; Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology 24:300–306[CrossRef]
SummersJ.,
MasonW. S.1982; Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403–415[CrossRef]
SummersJ.,
O'; ConnellA.,
MillmanI.
1975; Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Natl Acad Sci U S A 72:4597–4601[CrossRef]
TangH.,
RaneyA. K.,
McLachlanA.2001; Replication of the wild type and a natural hepatitis B virus nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture. J Virol 75:8937–8948[CrossRef]
TuttlemanJ. S.,
PourcelC.,
SummersJ.1986; Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47:451–460[CrossRef]
YuX.,
MertzJ. E.1997; Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily. J Virol 71:9366–9374
ZhengY.,
LiJ.,
OuJ. H.2004; Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J Virol 78:6908–6914[CrossRef]